A Phase 2 study for NT219 in combination with immunotherapy is being conducted in collaboration with the University of Colorado REHOVOT, Israel, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ...
A Phase 2 study for NT219 in combination with immunotherapy is being conducted in collaboration with the University of Colorado This application, if granted, is expected to provide broad protection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback